Literature DB >> 16559085

Mode of action of nitrofurazone.

D R McCalla1, A Reuvers, C Kaiser.   

Abstract

When Escherichia coli strain B/r is exposed to 10 to 20 mug of nitrofurazone per ml, mutants with roughly threefold resistance are obtained. Treatment of these mutants with higher concentrations of nitrofurazone yields strains with six- to seven-fold resistance over strain B/r. Each of these steps toward nitrofurazone resistance is accompanied by loss of soluble nitrofurazone reductase activity. When sensitive bacteria are exposed to labeled nitrofurazone or labeled 2-nitrofuran, a considerable amount of radioactivity becomes bound to the cold trichloroacetic acid-insoluble fraction. Very little activity becomes bound in the mutants with six- to seven-fold resistance; mutants with intermediate resistance show intermediate levels of binding. Partially purified nitrofurazone reductase preparations catalyze the conversion of nitrofurazone to compounds which bind to protein and are not removed by prolonged dialysis against 8 m urea or by cold acid. Nitrofurazone reduced by xanthine oxidase or electrolytically reduced also yields compounds which react with protein to form stable derivatives.

Entities:  

Year:  1970        PMID: 16559085      PMCID: PMC248269          DOI: 10.1128/jb.104.3.1126-1134.1970

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  18 in total

1.  INDUCTION OF PHAGE FORMATION BY NITROFURANS.

Authors:  W E WATERBURY; R FREEDMAN
Journal:  Can J Microbiol       Date:  1964-12       Impact factor: 2.419

2.  EFFECT OF SOME RADIOMIMETIC AGENTS ON DEOXYRIBONUCLEIC ACID SYNTHESIS IN ESCHERICHIA COLI AND TRANSFORMATION IN BACILLUS SUBTILIS.

Authors:  A TERAWAKI; J GREENBERG
Journal:  Biochim Biophys Acta       Date:  1965-01-11

3.  EFFECT OF NITROFURANS ON THE CHLOROPLAST SYSTEM OF EUGLENA GRACILIS.

Authors:  D R MCCALLA
Journal:  J Protozool       Date:  1965-02

4.  NITROFURAN DERIVATIVES AS RADIOMIMETIC AGENTS: CROSS-RESISTANCE STUDIES WITH ESCHERICHIA COLI.

Authors:  D R MCCALLA
Journal:  Can J Microbiol       Date:  1965-04       Impact factor: 2.419

5.  Cytological analysis of ultraviolet-irradiated Escherichia coli. III. Reactions of a sensitive strain and its resistant mutants.

Authors:  P E HARTMAN; S MUDD; J I PAYNE; A W PHILLIPS
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

6.  The reduction of Furacin by cell-free extracts of Furacin-resistant and parent-susceptible strains of Escherichia coli.

Authors:  R E ASNIS
Journal:  Arch Biochem Biophys       Date:  1957-01       Impact factor: 4.013

7.  Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics.

Authors:  W SZYBALSKI; V BRYSON
Journal:  J Bacteriol       Date:  1952-10       Impact factor: 3.490

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  Metabolism of the nitrofurans. III. Studies with xanthine oxidase in vitro.

Authors:  J D TAYLOR; H E PAUL; M F PAUL
Journal:  J Biol Chem       Date:  1951-07       Impact factor: 5.157

10.  RESISTANCE AND CROSS RESISTANCE OF ESCHERICHIA COLI S MUTANTS TO THE RADIOMIMETIC AGENT NITROFURAZONE.

Authors:  P WOODY-KARRER; J GREENBERG
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

View more
  29 in total

1.  Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.

Authors:  Sandra J Aedo; Juechun Tang; Mark P Brynildsen
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology.

Authors:  Tove Grönroos; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10       Impact factor: 9.236

3.  Genetics of nitrofurazone resistance in Escherichia coli.

Authors:  D R McCalla; C Kaiser; M H Green
Journal:  J Bacteriol       Date:  1978-01       Impact factor: 3.490

4.  Nitrofurantoin-resistant mutants of Escherichia coli: isolation and mapping.

Authors:  S S Sastry; R Jayaraman
Journal:  Mol Gen Genet       Date:  1984

5.  Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.

Authors:  L A Spry; T V Zenser; S M Cohen; B B Davis
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

6.  Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.

Authors:  J Whiteway; P Koziarz; J Veall; N Sandhu; P Kumar; B Hoecher; I B Lambert
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

7.  Antibacterial activity of nitropyrroles, nitrothiphenes, and aminothiophenes in vitro.

Authors:  C Y Wang; C W Chiu; K Muraoka; P D Michie; G T Bryan
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

8.  Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coli.

Authors:  W Suter; A Rosselet; F Knüsel
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

9.  Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.

Authors:  D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

10.  A DinB variant reveals diverse physiological consequences of incomplete TLS extension by a Y-family DNA polymerase.

Authors:  Daniel F Jarosz; Susan E Cohen; James C Delaney; John M Essigmann; Graham C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.